Norway· NO-ID_A8D961F8-1E72-4C13-A2D8-84665B3CE1D4
Quviviq
A daridorexant product containing daridorexant, registered in Norway by Idorsia. The same ATC class is registered in 15 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Daridorexant is registered in 15 of 19 countries.
Countries holding a registration under ATC N05CJ03 (daridorexant), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 10 of them publish a price we can compare per daily dose
Daridorexant · ATC N05CJ03
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of daridorexant costs, country by country.
Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Daridorexant · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- FR France$3.24
The record
At a glance
FEST (Norway)- Active substance
- Daridorexant
- Manufacturer
- Idorsia
- Country
- Norway (NO)
- ATC code
- N05CJ03
- ATC class
- Daridorexant
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 2
- no_merkevare_idID_A8D961F8-1E72-4C13-A2D8-84665B3CE1D4
- no_varenummer20215430
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Daridorexant in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaQUVIVIQIDORSIA PHARMACEUTICALS LTD
- United KingdomQuviviq 50mg tabletsIdorsia Pharmaceuticals UK Ltd
- CzechiaQUVIVIQIdorsia Pharmaceuticals Deutschland GmbH, Lörrach
- SwitzerlandQUVIVIQ 25 mg , FilmtablettenIdorsia Pharmaceuticals Ltd
- FinlandQUVIVIQParanova Oy
- United StatesQUVIVIQIdorsia Pharmaceuticals Ltd
- SpainQUVIVIQ 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULAIdorsia Pharmaceuticals Deutschland Gmbh
- BelgiumQuviviq 25 mgIdorsia Pharmaceuticals Deutschland
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Quviviq
- Liechtenstein · Quviviq
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/62119806-3f39-4979-ac44-017d78037850 GET /v1/drugs/62119806-3f39-4979-ac44-017d78037850?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett",
"source": "fest",
"status": "A",
"atc_name": "Daridoreksant",
"merkevare_id": "ID_A8D961F8-1E72-4C13-A2D8-84665B3CE1D4",
"name_form_strength": "Quviviq tab 50 mg",
"prescription_group": "C"
}See everything about daridorexant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.